Safe-R: a novel score, accounting for oncological safe nerve-sparing at radical prostatectomy for localized prostate cancer
暂无分享,去创建一个
T. Schlomm | H. Heinzer | M. Graefen | U. Michl | T. Steuber | P. Tennstedt | L. Kluth | A. Becker | Meike Adam | Carolina Coelius
[1] S. Stampf. Stratification and matching by the propensity score , 2014 .
[2] Shyam Natarajan,et al. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. , 2014, European urology.
[3] I. Christensen,et al. Risk factors associated with positive surgical margins following radical prostatectomy for clinically localized prostate cancer: Can nerve-sparing surgery increase the risk? , 2014, Scandinavian journal of urology.
[4] M. Brock,et al. Intraoperative frozen section of the prostate decreases positive margin rate while ensuring nerve sparing procedure during radical prostatectomy. , 2013, The Journal of urology.
[5] A. Haese*,et al. Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients. , 2012, European urology.
[6] B. Guillonneau,et al. A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes. , 2012, European urology.
[7] L. Holmberg,et al. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial. , 2011, The Lancet. Oncology.
[8] A. Haese*,et al. Full functional-length urethral sphincter preservation during radical prostatectomy. , 2011, European urology.
[9] K. Palmer,et al. Pentafecta: a new concept for reporting outcomes of robot-assisted laparoscopic radical prostatectomy. , 2011, European urology.
[10] P. Scardino,et al. Pathological results and rates of treatment failure in high‐risk prostate cancer patients after radical prostatectomy , 2011, BJU international.
[11] A. Haese*,et al. Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stage. , 2010, The Journal of urology.
[12] A. Haese*,et al. Current technique of open intrafascial nerve-sparing retropubic prostatectomy. , 2009, European urology.
[13] A. Haese*,et al. Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men , 2008, Cancer.
[14] P. Pierorazio,et al. Preoperative risk stratification predicts likelihood of concurrent PSA-free survival, continence, and potency (the trifecta analysis) after radical retropubic prostatectomy. , 2007, Urology.
[15] W. Catalona,et al. Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer. , 2007, Urology.
[16] A. Morabito,et al. Restoration of posterior aspect of rhabdosphincter shortens continence time after radical retropubic prostatectomy. , 2006, The Journal of urology.
[17] A. Haese*,et al. Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy. , 2006, The Journal of urology.
[18] P. Scardino,et al. Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta"). , 2005, Urology.
[19] Hans Garmo,et al. Radical prostatectomy versus watchful waiting in early prostate cancer. , 2005, The New England journal of medicine.
[20] P. Carroll,et al. Utility of intraoperative frozen section analysis of surgical margins in region of neurovascular bundles at radical prostatectomy. , 2002, Urology.
[21] Colin B Begg,et al. Variations in morbidity after radical prostatectomy. , 2002, The New England journal of medicine.
[22] S B Malkowicz,et al. Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era. , 2001, The Journal of urology.
[23] U Pichlmeier,et al. A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy. , 2001, The Journal of urology.
[24] M. Kattan,et al. Factors predicting recovery of erections after radical prostatectomy. , 2000, The Journal of urology.
[25] M. Litwin,et al. Intraoperative frozen section monitoring of nerve sparing radical retropubic prostatectomy. , 1999, The Journal of urology.
[26] N. Olson,et al. Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy. , 1993, The Journal of urology.
[27] C. Stocking,et al. Sex or survival: trade-offs between quality and quantity of life. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] J. Epstein. Evaluation of Radical Prostatectomy Capsular Margins of Resection: The Significance of Margins Designated as Negative, Closely Approaching, and Positive , 1990, The American journal of surgical pathology.
[29] T. Stamey,et al. Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread , 1988, The American journal of surgical pathology.
[30] I. Thompson,et al. Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] L. Salomon. Re: Bianco FJ, Scardino PT, and Eastham JA: Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("Trifecta") (Urology 66(5 suppl): 83-94, 2005). , 2008, Urology.
[32] D. Gleason,et al. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. , 1974, The Journal of urology.